Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine for iron overload disorders
2008-000360-16Phase 3Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nifedipine in hereditary hemochromatosis (HH) and Secondary Hemosiderosis (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Change in serum ferritin. Started Jul 2009; status: terminated.
02
Drugs
nifedipine
03
Conditions
hereditary hemochromatosis (HH)Secondary Hemosiderosis
Beyond the preview
Go deeper on 2008-000360-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000360-16.